What do systematic reviews say?

145 questions · 145 findings · 59 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 145 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

NB‐UVB vs placebo

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Methotrexate vs other DMARDs

Health‐related quality of life ‐ not measured · psoriatic arthritis

The review found no eligible studies for this question.

1 finding from 1 review

Methotrexate for psoriatic arthritis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rilonacept vs indomethacin

Health‐related quality of life ‐ not measured · acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Canakinumab vs triamcinolone acetonide

Health‐related quality of life ‐ not measured · acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Health‐related quality of life ‐ not measured · patients with acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Lifestyle interventions for acute gout 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Paliperidone palmitate vs risperidone long‐acting injection

Health related quality of life ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Paliperidone palmitate vs placebo

Health‐related quality of life ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intravesically administered BCG alternating with IFN‐α vs intravesically administered BCG alone

Disease‐specific quality of life ‐ not reported · patients with non‐muscle invasive bladder cancer

The review found no eligible studies for this question.

1 finding from 1 review

Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating… 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intravesically administered BCG combined with IFN‐α vs intravesically administered BCG alone

Disease‐specific quality of life ‐ not reported · patients with non‐muscle invasive bladder cancer

The review found no eligible studies for this question.

1 finding from 1 review

Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating… 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Motivational interviewing vs usual care

Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse

The review found no eligible studies for this question.

1 finding from 1 review

Psychosocial interventions for people with both severe mental illness and substance misuse 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SKILLS TRAINING vs usual care

Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse

The review found no eligible studies for this question.

1 finding from 1 review

Psychosocial interventions for people with both severe mental illness and substance misuse 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

COGNITIVE BEHAVIOUR THERAPY and PSYCHOSOCIAL REHABILITATION vs usual care

Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse

The review found no eligible studies for this question.

1 finding from 1 review

Psychosocial interventions for people with both severe mental illness and substance misuse 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cognitive behavioural therapy + intensive case management vs usual care

Quality of life/life satisfaction ‐ not measured · people with both severe mental illness and substance misuse

The review found no eligible studies for this question.

1 finding from 1 review

Psychosocial interventions for people with both severe mental illness and substance misuse 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Virtual reality plus usual care vs usual care

Quality of life ‐ not measured in any of the studies · people receiving stroke rehabilitation

The review found no eligible studies for this question.

1 finding from 1 review

Virtual reality for stroke rehabilitation 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Metformin + megestrol vs megestrol

HRQOL ‐ not measured · endometrial hyerplasia

The review found no eligible studies for this question.

1 finding from 1 review

Metformin for endometrial hyperplasia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs megestrol

HRQOL ‐ not measured · endometrial hyperplasia

The review found no eligible studies for this question.

1 finding from 1 review

Metformin for endometrial hyperplasia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Licochalcone‐containing moisturiser vs hydrocortisone acetate 1% cream

Change from baseline in quality of life ‐ not measured · people with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vehicle treatment + daily moisturiser vs fluticasone propionate twice weekly + daily moisturiser

Change from baseline in quality of life ‐ not measured · people with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupuncture vs gastrokinetic agents

Quality of life (either short or long term) ‐ not measured · symptomatic gastroparesis

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for symptomatic gastroparesis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupuncture vs non‐gastrokinetic agents

Quality of life (either short or long term) ‐ not measured · symptomatic gastroparesis

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for symptomatic gastroparesis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found